Showing results (161-170 of 268) with videos related to

Sort By:
Pageof 27
Chest|October 8, 2020
Essential Components of an Interstitial Lung Disease Clinic: Results From a Delphi Survey and Patient Focus Group AnalysisBridget A Graney, Christophe He, Michael Marll, et al.
Chest|November 7, 2016
Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity PneumonitisJulie Morisset, Kerri A Johannson, Eric Vittinghoff, et al.
Chest|February 9, 2013
Radiographic fibrosis score predicts survival in hypersensitivity pneumonitisJoshua J Mooney, Brett M Elicker, Thomas H Urbania, et al.
The Lancet. Respiratory Medicine|August 4, 2018
Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trialsMargaret Neighbors, Christopher R Cabanski, Thirumalai R Ramalingam, et al.
Population Health Management|August 12, 2009
The effects of a computer-tailored message on secondary prevention in type 2 diabetes: a randomized trialSandra Y Adams, Albert G Crawford, Rajiv N Rimal, et al.
BMJ Open Respiratory Research|October 12, 2017
Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung diseaseKevin R Flaherty, Kevin K Brown, Athol U Wells, et al.
Plos One|July 1, 2016
miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary FibrosisSupparerk Disayabutr, Eun Kyung Kim, Seung-Ick Cha, et al.
Thorax|March 3, 2017
CXCL14 is a candidate biomarker for Hedgehog signalling in idiopathic pulmonary fibrosisGuiquan Jia, Sanjay Chandriani, Alexander R Abbas, et al.
The European Respiratory Journal|April 23, 2015
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trialsHarold R Collard, Williamson Z Bradford, Vincent Cottin, et al.
The Journal of Clinical Investigation|August 11, 2010
Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liverDirk Grimm, Lora Wang, Joyce S Lee, et al.
Pageof 27